SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abbott Vascular XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy